These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31028202)

  • 81. ETS-1 proto-oncogene as a key newcomer molecule to predict invasiveness in laryngeal carcinoma.
    Calli AO; Sari A; Cakalagaoglu F; Altinboga AA; Oncel S
    Pathol Res Pract; 2011 Oct; 207(10):628-33. PubMed ID: 21940109
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma.
    Papanikolaou V; Chrysovergis A; Mastronikolis S; Tsiambas E; Ragos V; Peschos D; Spyropoulou D; Pantos P; Niotis A; Mastronikolis N; Kyrodimos E
    In Vivo; 2021; 35(3):1611-1615. PubMed ID: 33910843
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Effect of expression of p53 in squamous cell carcinoma of larynx and mucosa adjacent to tumor on the biological behavior].
    Luo K; Wang Z; Wang N; Zhang X; Yang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 May; 19(9):405-8. PubMed ID: 16075975
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Cancer Lett; 2002 Mar; 177(1):13-9. PubMed ID: 11809526
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma.
    Starska K; Brys M; Forma E; Glowacka E; Lewy-Trenda I; Stasikowska O; Krajewska WM; Lukomski M
    Oncol Rep; 2009 Feb; 21(2):539-48. PubMed ID: 19148533
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Expression of microtubule-associated protein 1 light chain 3 in laryngeal carcinoma].
    Wan B; Dong J; Wang L; Zhang S; Kong W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 25(11):497-500. PubMed ID: 21845828
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma.
    Miyaguchi M; Olofsson J; Hellquist HB
    Acta Otolaryngol; 1990; 110(3-4):309-13. PubMed ID: 2239223
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Significance of p16 and C-myc expression in the laryngeal squamous cell carcinoma].
    Peng J; Zeng Y; Xu Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 11(8):352-5. PubMed ID: 10323033
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Detection of an EML4-ALK fusion mutation secondary to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer: a case report.
    Ren KH; Qin WW; Wang Y; Peng JC; Hu WX
    Ann Palliat Med; 2022 Jul; 11(7):2503-2509. PubMed ID: 35927783
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical significance of integrin-linked kinase in laryngeal squamous cell carcinoma.
    Wu PA; Li SS; Tang QL; Liu BB; Yang XM
    Auris Nasus Larynx; 2017 Aug; 44(4):458-463. PubMed ID: 28188026
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.
    Fang W; Shen J
    Am J Otolaryngol; 2020; 41(3):102391. PubMed ID: 31932027
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Expression and role of survivin in laryngeal squamous cell carcinoma and laryngeal papilloma in adults].
    Xie H; Zhang B; Yin J; Song F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(9):413-6. PubMed ID: 17634026
    [TBL] [Abstract][Full Text] [Related]  

  • 94. ALK immunohistochemistry is highly sensitive and specific for the detection of ALK translocated lung adenocarcinomas: lessons from an audit of lung cancer molecular testing.
    Kheng YC; Walsh K; Williams L; Wallace WA; Harrison DJ; Oniscu A
    J R Coll Physicians Edinb; 2018 Mar; 48(1):20-24. PubMed ID: 29741520
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance].
    Lin P; Wang W; Cai WJ; Han CR; Sun Y; Li M; Sun BC
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):480-5. PubMed ID: 19954019
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
    Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
    Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.
    Kalfert D; Celakovsky P; Laco J; Ludvikova M
    Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Wild-Type Anaplastic Lymphoma Kinase Expression in Solitary Pulmonary Nodules: A Potential Marker for Primary Lung Squamous Cell Carcinoma in Patients With Previous Neck Squamous Cell Carcinoma.
    Takanashi Y; Shinmura K; Sekihara K; Ishikawa R; Funai K
    Cureus; 2024 Apr; 16(4):e58051. PubMed ID: 38738001
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Clinical Significance of CD163+ Tumor-Associated Macrophages (TAMs) in Laryngeal Squamous Cell Carcinoma.
    Ouban A; Raddaoui E; Bakir M
    Cureus; 2023 Mar; 15(3):e36339. PubMed ID: 37082492
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma.
    Yokoi A; Nakamura Y; Hashimura M; Oguri Y; Matsumoto T; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Saegusa M
    BMC Cancer; 2023 Aug; 23(1):765. PubMed ID: 37592266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.